REFERENCES
- Tsimberidou A. M., O'Brien S., Khouri I., et al. Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. J Clin Oncol 2006; 24(15)2343–2351
- Tsimberidou A. M., Keating M. J. Richter syndrome: Biology, incidence, and therapeutic strategies. Cancer 2005; 103(2)216–228
- Robertson L. E., Pugh W., O'Brien S., et al. Richter's syndrome: A report on 39 patients. J Clin Oncol 1993; 11(10)1985–1989
- Ohno T., Smir B. N., Weisenburger D. D., et al. Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with “Hodgkin's transformation. Blood 1998; 91(5)1757–1761
- Fong D., Kaiser A., Spizzo G., et al. A Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukemia patients previously treated with fludarabine. Br J Haematol 2005; 129(2)199–205
- Mao Z., Quintanilla-Martinez L., Raffeld M., et al. IgVH mutational status and clonality analysis of Richter's transformation: Diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 2007; 31(10)1605–1614
- Kanzler H., Kuppers R., Helm S., et al. Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: Potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 2000; 95(3)1023–1031
- Adiga G. U., Abebe L., Wiernik P. H. Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: Case report and literature review. Am J Hematol 2003; 72(4)267–273
- Re D., Fuchs M., Schober T., et al. CNS involvement in Hodgkin's lymphoma. J Clin Oncol 2007; 25(21)3182
- Hirmiz K., Foyle A., Wilke D., et al. Intracranial presentation of systemic Hodgkin's disease. Leuk Lymphoma 2004; 45(8)1667–1671
- Tsimberidou A. M., O'Brien S., Kantarjian H. M., et al. Hodgkin transformation of chronic lymphocytic leukemia: The M.D. Anderson Cancer Center experience. Cancer
- Vanden Berg A., Maggio E., Rust R., et al. Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. Blood 2002; 100(4)1425–1429
- Isikdogan A., Ayyildiz O., Buyukbayram H., et al. Hodgkin's disease variant of Richter's transformation: A case report. Med Oncol 2002; 19(2)109–112
- Robak T., Szmigielska-Kaplon A., Smolewski P., et al. Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide. Leuk Lymphoma 2003; 44(5)859–866
- Alliot C., Tabuteau S., Desablens B. Hodgkin's disease variant of Richter's syndrome: Complete remission of the both malignancies after 14 years. Hematology 2003; 8(4)229–231
- Nemets A., Ben Dor D., Barry T., et al. Variant Richter's syndrome: A rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine. Leuk Lymphoma 2003; 44(12)2151–2154
- De Leval L., Vivario M., De Prijck B., et al. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. Am J Surg Pathol 2004; 28(5)679–686
- Fong D., Kaiser A., Spizzo G., et al. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukemia patients previously treated with fludarabine. Br J Haematol 2005; 129(2)199–205
- Sheehan T., Cuthbert R. J., Parker A. C. Central nervous system involvement in haematological malignancies. Clin. Lab. Haematol 1989; 11: 331–338
- Nakayaama H., Tokuuye K., Kagami Y., et al. Brain involvement in Hodgkin's disease: Case reports and review of literature. Radiation Medicine 2000; 8: 205–208
- Orlowski E. P., Hansen R. M., Anderson T., et al. Hodgkin's disease with leptomeningeal involvement, report of a case with long survival. Cancer 1984; 53: 1833–1835
- Chim C. S., Shek T. W., Ooi G. C., et al. Unusual features of Hodgkin's disease. Case 2: Meningeal relapse in Hodgkin's disease. J. Clin. Oncol 2000; 18: 1153–1155
- Taylor C. R., Russell R., Lukes R. J., et al. An immunohistological study of immunoglobulin content of primary central nervous system lymphomas. Cancer 1978; 41(6)2197–2205
- Cheson B. D., Vena D. A., Barrett J., et al. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J Clin Oncol 1999; 17(8)2454–2460
- Maddocks-Christianson K., Slager S. L., Zent C. S., et al. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia. Br J Haematol 2007; 139(3)398–404
- Lazzarino M., Orlandi E., Baldanti F., et al. The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. Br J Haematol 1999; 107(4)877–882
- Abruzzo L. V., Rosales C. M., Medeiros L. J., et al. Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms. Am J Surg Pathol 2002; 26(5)630–636